TOKYO (Reuters) – A research in Japan discovered that girls had been considerably extra doubtless than males to develop rash-like unintended effects after a primary dose of Moderna (NASDAQ:) Inc’s COVID-19 vaccine.

The research of 5,893 members between Could and November final yr confirmed that 22.4% of girls developed delayed pores and skin reactions after the primary shot, in comparison with 5.1% of males.

The signs had been gentle and never thought-about a contraindication of the mRNA-based vaccine, in keeping with the June 1 report within the Journal of the American Medical Affiliation.

Delayed pores and skin reactions, occurring on or after six days from the shot, have been additionally reported as a uncommon antagonistic occasion in america and Europe, in keeping with the authors from Tokyo’s Self-Protection Forces Central Hospital.

However the incidences look like increased in Japan, they wrote, maybe due to a better consciousness of such signs within the nation. The higher probability amongst girls could also be as a result of variations in weight in addition to hormonal and environmental elements, they stated.

Moderna representatives in america and Japan didn’t instantly reply to a request for remark.